Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii
Clinical trials sponsored by Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii, explained in plain language.
-
Common painkiller tested as potential Heart-Scarring treatment
Disease control Recruiting nowThis study is testing whether a 3-week course of ibuprofen works better than standard pain relievers like acetaminophen to reduce heart scarring in people recovering from acute myocarditis (heart inflammation). Researchers will follow 150 patients for a year, using heart scans to…
Phase: PHASE3 • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Arm cuff trial aims to shield hearts from chemo damage
Disease control Recruiting nowThis study is testing whether a simple, non-invasive procedure called remote ischemic conditioning can protect the heart in lymphoma patients receiving a common but potentially heart-damaging chemotherapy. Over 600 patients at risk for heart problems will be randomly assigned to …
Phase: NA • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC